E
Enrique Quintero
Researcher at Hospital Universitario de Canarias
Publications - 210
Citations - 10505
Enrique Quintero is an academic researcher from Hospital Universitario de Canarias. The author has contributed to research in topics: Colonoscopy & Colorectal cancer. The author has an hindex of 44, co-authored 201 publications receiving 9415 citations. Previous affiliations of Enrique Quintero include Veterans Health Administration & University of Las Palmas de Gran Canaria.
Papers
More filters
Journal ArticleDOI
Compensated cirrhosis: natural history and prognostic factors.
Pere Ginès,Enrique Quintero,Vicente Arroyo,Josep Terés,Miguel Bruguera,Antoni Rimola,Joan Caballería,Joan Rodés,Ciril Rozman +8 more
TL;DR: To investigate the natural history of compensated cirrhosis, 293 consecutive patients without previous major complications were studied in terms of morbidity and survival and a prognostic index was constructed that allows calculation of the estimated survival probability.
Journal ArticleDOI
Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening
Enrique Quintero,Antoni Castells,Luis Bujanda,Joaquín Cubiella,Dolores Salas,Angel Lanas,Montserrat Andreu,Fernando Carballo,Juan Diego Morillas,Cristina Hernández,Rodrigo Jover,Isabel Montalvo,Juan Arenas,Eva Laredo,Vicent Hernandez,Felipe Iglesias,Estela Cid,Raquel Zubizarreta,Teresa Sala,Marta Ponce,Mercedes Andrés,Gloria Teruel,Antonio Peris,María-Pilar Roncales,Mónica Polo-Tomás,Xavier Bessa,Olga Ferrer-Armengou,Jaume Grau,Anna Serradesanferm,Akiko Ono,José Cruzado,Francisco Pérez-Riquelme,Inmaculada Alonso-Abreu,Mariola de la Vega-Prieto,Juana María Reyes-Melián,Guillermo Cacho,José Díaz-Tasende,Alberto Herreros-de-Tejada,Carmen Poves,Cecilio Santander,Andrés González-Navarro +40 more
TL;DR: Subjects in the FIT group were more likely to participate in screening than were those in the colonoscopy group, and more adenomas were identified in thecolorectal cancer group.
Journal ArticleDOI
Primary Prophylaxis of Spontaneous Bacterial Peritonitis Delays Hepatorenal Syndrome and Improves Survival in Cirrhosis
Javier Fernández,Miquel Navasa,Ramon Planas,Silvia Montoliu,David Monfort,Germán Soriano,Carmen Vila,Alberto Pardo,Enrique Quintero,Victor Vargas,José Such,Pere Ginès,Vicente Arroyo +12 more
TL;DR: In this paper, the authors showed that primary prophylaxis with norfloxacin has a great impact in the clinical course of patients with advanced cirrhosis, reducing the incidence of spontaneous bacterial peritonitis, delaying the development of hepatorenal syndrome, and improving survival.
Journal ArticleDOI
Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations
Angel Lanas,Luis A García-Rodríguez,María Teresa Arroyo,Fernando Gomollón,Faust Feu,Antonio González-Pérez,E Zapata,G Bástida,Luis Rodrigo,Santos Santolaria,M Güell,C M de Argila,Enrique Quintero,Fernando Borda,J M Piqué +14 more
TL;DR: Coxib use presents a lower RR of UGIB than non-selective NSAIDs, however, when combined with low-dose aspirin, the differences between non-selection NSAIDs and coxibs tend to disappear.
Journal ArticleDOI
Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
Cesare Hassan,Enrique Quintero,Jean-Marc Dumonceau,Jaroslaw Regula,Catarina Brandão,Stanislas Chaussade,Evelien Dekker,Mário Dinis-Ribeiro,Monika Ferlitsch,Antonio Z. Gimeno-García,Yark Hazewinkel,Rodrigo Jover,Mette Kalager,Magnus Løberg,Magnus Løberg,Christian Pox,B. Rembacken,David A. Lieberman +17 more
TL;DR: The following recommendations for post-polypectomy endoscopic surveillance should be applied only after a high quality baseline colonoscopy with complete removal of all detected neoplastic lesions.